A 52-year-old man with a 15-year history of type 2 diabetes mellitus presents with a 1-week history of severe vomiting and abdominal pain. He has been fasting due to illness. On examination: BP 92/58 mmHg, HR 118/min, RR 32/min, and breath has a fruity odor. Laboratory findings: pH 7.22, HCO₃⁻ 10 mEq/L, PaCO₂ 24 mmHg, glucose 320 mg/dL, β-hydroxybutyrate 6.8 mmol/L (normal <0.6). Serum osmolality is 310 mOsm/kg. Urine ketones are strongly positive. Which tissue is responsible for the primary synthesis of the ketone bodies that are accumulating in this patient's blood?

Explanation

## Ketone Body Synthesis: Organ and Enzyme Specificity **Key Point:** The LIVER is the primary and almost exclusive site of ketone body synthesis, catalyzed by hepatic mitochondrial enzymes, particularly HMG-CoA synthase-2. ### Hepatic Ketogenesis: The Three-Step Pathway ```mermaid flowchart TD A[Fatty Acids from Adipose Tissue]:::outcome --> B[β-Oxidation in Hepatic Mitochondria] B --> C[Acetyl-CoA Accumulation] C --> D[HMG-CoA Synthase-2]:::action D --> E[HMG-CoA] E --> F[HMG-CoA Lyase]:::action F --> G[Acetoacetate] G --> H[Lactate Dehydrogenase] H --> I[β-Hydroxybutyrate]:::outcome I --> J[Released into Bloodstream] J --> K[Utilized by Extrahepatic Tissues] ``` ### Step-by-Step Mechanism 1. **β-Oxidation:** Fatty acids undergo mitochondrial β-oxidation → multiple acetyl-CoA molecules 2. **HMG-CoA Synthase-2 (HMGCS2):** Condenses 2 acetyl-CoA → HMG-CoA (rate-limiting step) - **High-Yield:** HMGCS2 is the KEY regulatory enzyme; it is upregulated during fasting and DKA - Located exclusively in liver (and kidney, to a minor extent) 3. **HMG-CoA Lyase:** Cleaves HMG-CoA → acetoacetate + acetyl-CoA 4. **Lactate Dehydrogenase:** Reduces acetoacetate → β-hydroxybutyrate (predominant ketone in severe ketosis) ### Why the Liver? | Tissue | Ketone Synthesis | Ketone Utilization | Role | |--------|------------------|-------------------|------| | **Liver** | ✓✓✓ (Primary) | ✗ (lacks thiophorase) | Producer | | **Kidney** | ✓ (Minor ~10%) | ✓ | Producer + consumer | | **Brain** | ✗ | ✓✓✓ | Consumer | | **Heart** | ✗ | ✓✓✓ | Consumer | | **Adipose** | ✗ | ✗ | Substrate provider (FFA) | | **Muscle** | ✗ | ✓ | Consumer | **Clinical Pearl:** The liver CANNOT use its own ketone bodies because it lacks **succinyl-CoA transferase (thiophorase)**, the enzyme needed to activate acetoacetate back to acetyl-CoA. This ensures ketones are exported for use by other tissues. ### Regulation of Hepatic Ketogenesis **High-Yield:** HMGCS2 is regulated by: - **Fasting/DKA:** Increased glucagon, decreased insulin → ↑ HMGCS2 expression - **Malonyl-CoA:** Acts as an allosteric inhibitor of HMGCS2 (in addition to inhibiting CPT-1) - **Acetyl-CoA levels:** Substrate availability drives the reaction forward **Mnemonic:** **LIVER** = **L**ocus of ketone synthesis; **I**nhibited by malonyl-CoA; **V**ia HMGCS2; **E**xported to other tissues; **R**equires fasting/DKA ### In This Patient's Case The elevated β-hydroxybutyrate (6.8 mmol/L) reflects: - Severe fasting + vomiting → lipolysis → FFA release - Hyperglycemia + metabolic stress → increased hepatic HMGCS2 activity - Hepatic mitochondria overwhelmed with acetyl-CoA from β-oxidation - Ketone bodies accumulate faster than peripheral tissues can consume them → metabolic acidosis [cite:Lehninger Principles of Biochemistry Ch 23; Harrison 21e Ch 297]